In addition, TCSCs have the ability to express high quantities of programmed death ligand 1 (PD-L1), which trigger an ineffective anti-tumor immune response and promotes the development of an immunosuppressive surroundings by linking to the cognate receptor programmed death 1 (PD-1) on T cells (14). The gene discussed is CD274; the disease is neoplasm.